519MO Phase III EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9 trial of cemiplimab in recurrent or metastatic (R/M) cervical cancer: Long-term survival analysis

Journal article

Peer reviewed

A. Oaknin, B.J. Monk, L. Polastro, A. Cristina de Melo, H.S. Kim, Y.M. Kim, A.S. Lisyanskaya, V. Samouëlian, D. Lorusso, F.B. Damian, …

Annals of oncology, Vol.33, p.S781

09/2022

Metrics

2 Record Views

Title: 519MO Phase III EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9 trial of cemiplimab in recurrent or metastatic (R/M) cervical cancer: Long-term survival analysis
Creators: A. Oaknin
B.J. Monk
L. Polastro
A. Cristina de Melo
H.S. Kim
Y.M. Kim
A.S. Lisyanskaya
V. Samouëlian
D. Lorusso
F.B. Damian
C-L. Chang
S. Takahashi
D. Ramone
B. Maćkowiak-Matejczyk
J. Li
S. Jamil
M.D. Mathias
M.G. Fury
K.S. Tewari
Publication Details: Annals of oncology, Vol.33, p.S781
Identifiers: 991005968794502656
Academic Unit: Obstetrics & Gynecology
Language: English
Resource Type: Journal article